Risk Factors for QRS-Fragmentation in Patients with STEMI Undergoing PCI
<i>Background and Objectives</i>: Despite modern therapy algorithms, ST-elevation myocardial infarction (STEMI) substantially contributes to cardiovascular morbidity and mortality worldwide. Early Risk assessment is crucial to guide therapy allocation, especially in countries with limited healthcare resources. Electrocardiographic parameters such as QRS fragmentation (fQRS) evolved as an important prognostic marker. The underlying mechanisms and specific risk factors for the occurrence of fQRS in patients with STEMI undergoing PCI have not been analyzed yet. <i>Materials and Methods</i>: Between 09/2020 and 06/2021, out of 179 consecutive patients with STEMI undergoing primary percutaneous coronary intervention (pPCI), 122 patients were included in this study. The occurrence of fQRS was analyzed and correlated to clinical as well as biochemical parameters. <i>Results</i>: In this population, the fQRS pattern was present in 33.6% (n = 41) of patients. Besides gender, no statistically significant differences in baseline characteristics or comorbidities were observed between the two groups. In univariable logistic regression analysis, both glomerular filtration rate (GFR) (<i>p</i> = 0.050) and C-reactive protein (CRP) (<i>p</i> = 0.014) were significantly associated with the presence of fQRS. However, in the multivariable logistic regression model, only CRP levels on admission remained independently associated with fQRS (OR = 3.44, 95% CI: 1.95; 6.05), (<i>p</i> = 0.029). <i>Conclusions</i>: In this analysis, a correlation between fQRS and CRP levels in patients with STEMI undergoing pPCI could be demonstrated. Consequently, fQRS might serve as a marker for extensive inflammation in the context of myocardial ischemia.
Authors
- Irina Alexandrovna Lakman (ORCID: https://orcid.org/0000-0001-9876-9202)
- Rudin Pistulli (ORCID: https://orcid.org/0000-0001-7676-3942)
- R. F. Rakhimova (ORCID: https://orcid.org/0000-0002-2958-616X)
- Florian Tinhofer
- Н. Ш. Загидуллин (ORCID: https://orcid.org/0000-0003-2386-6707)
- Dilvin Semo (ORCID: https://orcid.org/0009-0005-4386-8533)
- Eduard F. Agletdinov (ORCID: https://orcid.org/0000-0002-6256-2020)
- Lukas J. Motloch (ORCID: https://orcid.org/0000-0002-5829-6743)
- K. A. Cheremisina (ORCID: https://orcid.org/0000-0002-4704-0785)
- Lukas Fiedler (ORCID: https://orcid.org/0000-0003-2626-3098)
- Christoph C. Kaufmann (ORCID: https://orcid.org/0000-0002-4710-0522)
- Е. А. Бадыкова (ORCID: https://orcid.org/0000-0002-8167-4271)
- A. V. Baraboshkina (ORCID: https://orcid.org/0000-0002-4091-4697)
- Dimitry M. Grishaev (ORCID: https://orcid.org/0009-0008-9081-6594)
Institutions
- Sigmund Freud Privatuniversität Wien (AT)
- Danube Private University (AT)
- Paracelsus Medical University (AT)
- State Research Center of Virology and Biotechnology VECTOR (RU)
- Fachhochschule Wiener Neustadt (AT)
- University Hospital Münster (DE)
- St. Marien Hospital (DE)
- Bashkir State Medical University (RU)
- Salzburger Landeskliniken (AT)
- Ufa State University of Economics and Service (RU)
Publication Details
- Journal
- Medicina
- Published
- 2025-11-12
- DOI
- https://doi.org/10.3390/medicina61112023
- Primary Topic
- Acute Myocardial Infarction Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00